Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 170–170 | Cite as

Dalbavancin

Drug-resistance and off-label use: case report
Case report
  • 13 Downloads

Reference

  1. Kussmann M, et al. Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis. Emerging Microbes and Infections 7: 202, No. 1, Dec 2018. Available from: URL: http://doi.org/10.1038/s41426-018-0205-z - Austria

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations